03.03.2015 Views

Disease staging: CliniCal anD CoDeD Criteria - HCUP

Disease staging: CliniCal anD CoDeD Criteria - HCUP

Disease staging: CliniCal anD CoDeD Criteria - HCUP

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Clinical <strong>Criteria</strong> with Description, Diagnostic Findings and ICD-9-CM codes<br />

DXCat Number: RES13<br />

MultiStage: No<br />

DXCat Label: Neoplasm, Malignant: Lungs, Bronchi, or Mediastinum Specificity: A<br />

Etiology: Neoplasm<br />

Stage Description Diagnostic findings ICD-9-CM Codes<br />

3.02 with distant metastasis Stage 3B of the American Joint Committee on <strong>staging</strong> of lung cancer<br />

STAGE 0.00-3.01 + (DX 1962-<br />

OR Stage 4 of the American Joint Committee on <strong>staging</strong> of lung cancer<br />

1969, 1973-1991, 78951, 20970-<br />

OR Stage T4 of the American Joint Committee on <strong>staging</strong> of lung cancer<br />

20979);<br />

OR Stage N3 of the American Joint Committee on <strong>staging</strong> of lung cancer<br />

OR Stage M1 of the American Joint Committee on <strong>staging</strong> of lung cancer<br />

OR Stage 1.01-3.01<br />

AND non-small cell metastasis to contralateral mediastinal lymph nodes,<br />

contralateral hilar lymph nodes, ipsilateral or contralateral scalene or<br />

supraclavicular lymph nodes [operative/pathology report]<br />

OR non-small cell a tumor of any size with invasion of the mediastinum,<br />

heart, great vessels, trachea, esophagus, vertebral body, or carina;<br />

or with a malignant pleural or pericardial effusion; or with satellite<br />

tumor nodules within the ipsilateral lobe of the lung containing the<br />

primary tumor [operative/pathology report]<br />

OR non-small cell distant metastasis [operative/pathology report]<br />

OR extensive small cell carcinoma [operative/pathology report]<br />

OR small cell carcinoma spread to more distant sites[operative/pathology report]<br />

3.03 with shock Stage 2.01-3.02<br />

AND shock:<br />

4.00 with death Stage 2.01-3.03<br />

AND death<br />

STAGE 0.00-3.02 + GROUP<br />

SHOCKN;<br />

NO;<br />

References:<br />

Minna JD. Neoplasms of the lung. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, eds. Harrison's Principles of Internal<br />

Medicine. 14th ed. New York, NY: McGraw-Hill; 1998:552-562.<br />

Spiro SG. Clinical trials in lung cancer: nihilism versus enthusiasm. Thorax. 1997;52(7):598-604.<br />

Stauffer JL. Lung. In: Tierney Jr LM, McPhee SJ, Papadakis MA, eds. Current Medical Diagnosis & Treatment. Stamford, CT: Appleton & Lange; 1998:251-333.<br />

Strauss GM, Gleason RE, Sugarbaker DJ. Screening for lung cancer. another look; a different view. Chest. 1997;111(3):754-68.<br />

Thursday, January 07, 2010 9:23:11 AM<br />

©2010 Thomson Reuters. All rights reserved.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!